Thousand Oaks, California, United States Amgen appeared to be the Corporate Investor, which was created in 1980. The company was established in North America in United States. The main department of described Corporate Investor is located in the Thousand Oaks.
The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2010. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. Considering the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Amgen performs on 15 percentage points less the average number of lead investments. The common things for fund are deals in the range of more than 100 millions dollars.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Amgen, startups are often financed by dievini Hopp Biotech Holding, Wellington Partners, AT Impf. The meaningful sponsors for the fund in investment in the same round are dievini Hopp Biotech Holding, Z Investments, Wellington Partners. In the next rounds fund is usually obtained by dievini Hopp Biotech Holding, Y Combinator, Wellington Partners.
Among the most popular fund investment industries, there are Medical, Manufacturing. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Oxford Nanopore Technologies, Unilife Corporation, Darmiyan. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Besides them, we counted 4 critical employees of this fund in our database.
Related Funds
| Fund Name | Location |
| AO Invest | - |
| Ascend Technology Ventures | - |
| ATAI Life Sciences | Bayern, Germany, Munich |
| Blueberry Ventures | California, San Francisco, United States |
| Brown Simpson Asset Management | Connecticut, Stamford, United States |
| E10 | - |
| Fischer Investment Capital (FIC) | New Jersey, Rumson, United States |
| Gresham House Ventures | England, London, United Kingdom |
| Kementerian Riset, Teknologi, dan Pendidikan Tinggi (Kemenristekdikti) | Indonesia, Jakarta Pusat, Jakarta Raya |
| KKR Real Estate Finance Trust | New York, New York, United States |
| Park Bench Capital | California, San Francisco, United States |
| Shanghai Hongjia Asset Management Co. | China, Shanghai |
| Sharq Ventures House | - |
| Thorndale Farm | Batavia, New York, United States |
| TSARI Capital | - |
| United States Navy | Arlington, United States, Virginia |
| Veneto Sviluppo | Italy, Marghera, Veneto |
| Xinrong Voyage Fund | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Neumora Therapeutics | $112M | 11 Oct 2022 | Watertown, Massachusetts, United States | ||
SomaLogic | $81M | 23 Dec 2020 | Boulder, Colorado, United States | ||
SiteOne Therapeutics | $15M | 06 Jan 2017 | Bozeman, Montana, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Neumora Therapeutics | $112M | 11 Oct 2022 | Watertown, Massachusetts, United States | ||
SomaLogic | $81M | 23 Dec 2020 | Boulder, Colorado, United States | ||
SiteOne Therapeutics | $15M | 06 Jan 2017 | Bozeman, Montana, United States |
